Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-05-07 @ 9:18 AM
Study NCT ID:
NCT05756569
Status:
RECRUITING
Last Update Posted:
2025-07-28
First Post:
2023-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
Sponsor:
Organization: